Imlygic 55513-0079
Generic: Talimogene Laherparepvec
Product NDC
55513-0079- Manufacturer
- Amgen Inc
- Dosage Form
- Injection, Suspension
- Route
- Intralesional
- Product Type
- Human Prescription Drug
- Marketing Start
- November 2, 2015
- Listing Expires
- December 31, 2026
- Application
- BLA125518
Need to source Imlygic? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Talimogene Laherparepvec | 100000000 [PFU]/mL |
Packaging Options(1)
1 VIAL in 1 CARTON (55513-079-01) / 1 mL in 1 VIAL